Generation of Retroviral Packaging and Producer Cell Lines for Large-Scale Vector Production and Clinical Application: Improved Safety and High Titer

This publication has 61 references indexed in Scilit:

• Human Gene Marker/Therapy Clinical Protocols (Complete Updated Listings)
  Human Gene Therapy, 1999
• Generation of a Systemic Antitumor Response with Regional Intratumoral Injections of InterferonγRetroviral Vector
  Human Gene Therapy, 1998
• Genetic Immunization of Chimpanzees Chronically Infected with the Hepatitis B Virus, Using a Recombinant Retroviral Vector Encoding the Hepatitis B Virus Core Antigen
  Human Gene Therapy, 1998
• A Simple and Reliable Method for Screening Retroviral Producer Clones Without Selectable Markers
  Human Gene Therapy, 1997
• Construction of Retroviral Vectors Carrying Human CD3γcDNA and Reconstitution of CD3γExpression and T Cell Receptor Surface Expression and Function in a CD3γ-Deficient Mutant T Cell Line
  Human Gene Therapy, 1997
• Episomal Vectors Rapidly and Stably Produce High-Titer Recombinant Retrovirus
  Human Gene Therapy, 1996
• Development of Amphotropic Murine Retrovirus Vectors Resistant to Inactivation by Human Serum
  Human Gene Therapy, 1996
• Cytotoxic T Lymphocyte and Antibody Responses Generated in Rhesus Monkeys Immunized with Retroviral Vector-Transduced Fibroblasts Expressing Human Immunodeficiency Virus Type-1 IIIB ENV/REV Proteins
  Human Gene Therapy, 1994
• Characterization of a Replication-Competent Retrovirus Resulting from Recombination of Packaging and Vector Sequences
  Human Gene Therapy, 1994
• Construction and use of a safe and efficient amphotropic packaging cell line
  Virology, 1988